Evaluation of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as inflammatory markers in patients with insulin resistance and rheumatoid arthritis: A Pilot study

Authors

  • Ms. Diptimayee Upadhyay,Dr. Subhashree Ray,Dr. Rajesh Kumar Bhola,Dr.A.K.Jayanthy Author

DOI:

https://doi.org/10.48047/y00h5f06

Keywords:

Rheumatoid Arthritis, Insulin Resistance, Neutrophil-Lymphocyte Ratio, Platelet Lymphocyte Ratio, Inflammatory Markers, Disease Activity, HOMA-IR

Abstract

BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory disorder of unknown etiology associated with insulin resistance (IR) and additional cardiovascular threats. Both disorders have inflammation as a key factor in their development. The NLR and PLR have been identified along with other inflammation indices that may be important in elucidating RA and IR's disease 
activity and inflammatory processes. 

Downloads

Download data is not yet available.

References

Aktas, G., Duman, T. T., Kurtkulagi, O., Tel, B. A., Bilgin, S., & Kahveci, G. (2020). Liver steatosis is associated with platelet distribution width, neutrophil/lymphocyte, and monocyte/lymphocyte ratios. Primary Health Care: Open Access, 10(4), 1-4.

Aletaha, D., & Smolen, J. S. (2018). Diagnosis and management of rheumatoid arthritis: a review. Jama, 320(13), 1360-1372.

Downloads

Published

2024-12-10

How to Cite

Evaluation of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as inflammatory markers in patients with insulin resistance and rheumatoid arthritis: A Pilot study (Ms. Diptimayee Upadhyay,Dr. Subhashree Ray,Dr. Rajesh Kumar Bhola,Dr.A.K.Jayanthy , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 1702-1719. https://doi.org/10.48047/y00h5f06